Short description
Sapheon is a medical device company developing new approaches and disruptive technologies for the treatment of vascular diseases.
Description
Sapheon is a medical device company whose mission is to develop new approaches and disruptive technologies for the treatment of vascular disease.
Sapheon Inc. is a medical device company whose mission is to develop new approaches and disruptive technologies for the treatment of vascular disease.
The company’s current focus is the VenaSeal Sapheon Closure System, a novel treatment for venous reflux disease. With full EU regulatory approval already in place, this game-changing approach to treating veins is poised to disrupt a $1 billion worldwide market.
The VenaSeal System uses a proprietary medical adhesive to close the saphenous vein, eliminating the need for surgery, ablation, anesthesia, or the use of harsh chemicals. Sapheon is actively preparing for U.S. clinical trials and FDA approval of the VenaSeal Sapheon Closure System.
Last funding
Noway Youcantaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Santa Rosa, California, United States, North America
Founded on
January 1, 2007
Exited on
August 28, 2014
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$1230 - 4560
Sign in for full access
Investors
Nopepepe
Sign in for full access
Founders
Don Crawford, Rod Raabe